Explore
Validate
LearnAntibody data
- Antibody Data
- Antigen structure
- References [17]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 600-101-196 - Provider product page
- Provider
- Rockland Immunochemicals, Inc.
- Proper citation
- Rockland Cat#600-101-196, RRID:AB_2056544
- Product name
- Anti-Apolipoprotein A-I (GOAT) Antibody - 600-101-196
- Antibody type
- Polyclonal
- Vial size
- 1 µl
Submitted references 10,12-Conjugated linoleic acid supplementation improves HDL composition and function in mice.
CREBH normalizes dyslipidemia and halts atherosclerosis in diabetes by decreasing circulating remnant lipoproteins.
Serum amyloid A-containing HDL binds adipocyte-derived versican and macrophage-derived biglycan, reducing its antiinflammatory properties.
Nascent HDL (High-Density Lipoprotein) Discs Carry Cholesterol to HDL Spheres: Effects of HDL Particle Remodeling on Cholesterol Efflux.
Serum amyloid A impairs the antiinflammatory properties of HDL.
Overexpression of Hsp27 ameliorates symptoms of Alzheimer's disease in APP/PS1 mice.
Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice.
siRNA-induced liver ApoB knockdown lowers serum LDL-cholesterol in a mouse model with human-like serum lipids.
Reduced body weight in male Tspan8-deficient mice.
Apolipoprotein B epitopes are present in nuclear preparations of human and mouse cells.
An apoA-I mimetic peptide increases LCAT activity in mice through increasing HDL concentration.
Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice.
Biogenesis of HDL by SAA is dependent on ABCA1 in the liver in vivo.
Expression profiling in APP23 mouse brain: inhibition of Abeta amyloidosis and inflammation in response to LXR agonist treatment.
Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expression.
High-fat/high-cholesterol diet promotes a S1P receptor-mediated antiapoptotic activity for VLDL.
Loss of polycystin-1 or polycystin-2 results in dysregulated apolipoprotein expression in murine tissues via alterations in nuclear hormone receptors.
Vaisar T, Wang S, Omer M, Irwin AD, Storey C, Tang C, den Hartigh LJ
Journal of lipid research 2022 Aug;63(8):100241
Journal of lipid research 2022 Aug;63(8):100241
CREBH normalizes dyslipidemia and halts atherosclerosis in diabetes by decreasing circulating remnant lipoproteins.
Shimizu-Albergine M, Basu D, Kanter JE, Kramer F, Kothari V, Barnhart S, Thornock C, Mullick AE, Clouet-Foraison N, Vaisar T, Heinecke JW, Hegele RA, Goldberg IJ, Bornfeldt KE
The Journal of clinical investigation 2021 Nov 15;131(22)
The Journal of clinical investigation 2021 Nov 15;131(22)
Serum amyloid A-containing HDL binds adipocyte-derived versican and macrophage-derived biglycan, reducing its antiinflammatory properties.
Han CY, Kang I, Omer M, Wang S, Wietecha T, Wight TN, Chait A
JCI insight 2020 Sep 24;5(20)
JCI insight 2020 Sep 24;5(20)
Nascent HDL (High-Density Lipoprotein) Discs Carry Cholesterol to HDL Spheres: Effects of HDL Particle Remodeling on Cholesterol Efflux.
Navdaev AV, Sborgi L, Wright SD, Didichenko SA
Arteriosclerosis, thrombosis, and vascular biology 2020 May;40(5):1182-1194
Arteriosclerosis, thrombosis, and vascular biology 2020 May;40(5):1182-1194
Serum amyloid A impairs the antiinflammatory properties of HDL.
Han CY, Tang C, Guevara ME, Wei H, Wietecha T, Shao B, Subramanian S, Omer M, Wang S, O'Brien KD, Marcovina SM, Wight TN, Vaisar T, de Beer MC, de Beer FC, Osborne WR, Elkon KB, Chait A
The Journal of clinical investigation 2016 Jan;126(1):266-81
The Journal of clinical investigation 2016 Jan;126(1):266-81
Overexpression of Hsp27 ameliorates symptoms of Alzheimer's disease in APP/PS1 mice.
Tóth ME, Szegedi V, Varga E, Juhász G, Horváth J, Borbély E, Csibrány B, Alföldi R, Lénárt N, Penke B, Sántha M
Cell stress & chaperones 2013 Nov;18(6):759-71
Cell stress & chaperones 2013 Nov;18(6):759-71
Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice.
Fitz NF, Cronican AA, Saleem M, Fauq AH, Chapman R, Lefterov I, Koldamova R
The Journal of neuroscience : the official journal of the Society for Neuroscience 2012 Sep 19;32(38):13125-36
The Journal of neuroscience : the official journal of the Society for Neuroscience 2012 Sep 19;32(38):13125-36
siRNA-induced liver ApoB knockdown lowers serum LDL-cholesterol in a mouse model with human-like serum lipids.
Tadin-Strapps M, Peterson LB, Cumiskey AM, Rosa RL, Mendoza VH, Castro-Perez J, Puig O, Zhang L, Strapps WR, Yendluri S, Andrews L, Pickering V, Rice J, Luo L, Chen Z, Tep S, Ason B, Somers EP, Sachs AB, Bartz SR, Tian J, Chin J, Hubbard BK, Wong KK, Mitnaul LJ
Journal of lipid research 2011 Jun;52(6):1084-1097
Journal of lipid research 2011 Jun;52(6):1084-1097
Reduced body weight in male Tspan8-deficient mice.
Champy MF, Le Voci L, Selloum M, Peterson LB, Cumiskey AM, Blom D
International journal of obesity (2005) 2011 Apr;35(4):605-17
International journal of obesity (2005) 2011 Apr;35(4):605-17
Apolipoprotein B epitopes are present in nuclear preparations of human and mouse cells.
Døssing K, Zaina S
International journal of molecular medicine 2009 Jul;24(1):29-33
International journal of molecular medicine 2009 Jul;24(1):29-33
An apoA-I mimetic peptide increases LCAT activity in mice through increasing HDL concentration.
Chen X, Burton C, Song X, McNamara L, Langella A, Cianetti S, Chang CH, Wang J
International journal of biological sciences 2009 Jul 28;5(5):489-99
International journal of biological sciences 2009 Jul 28;5(5):489-99
Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice.
de Haan W, van der Hoogt CC, Westerterp M, Hoekstra M, Dallinga-Thie GM, Princen HM, Romijn JA, Jukema JW, Havekes LM, Rensen PC
Atherosclerosis 2008 Mar;197(1):57-63
Atherosclerosis 2008 Mar;197(1):57-63
Biogenesis of HDL by SAA is dependent on ABCA1 in the liver in vivo.
Hu W, Abe-Dohmae S, Tsujita M, Iwamoto N, Ogikubo O, Otsuka T, Kumon Y, Yokoyama S
Journal of lipid research 2008 Feb;49(2):386-93
Journal of lipid research 2008 Feb;49(2):386-93
Expression profiling in APP23 mouse brain: inhibition of Abeta amyloidosis and inflammation in response to LXR agonist treatment.
Lefterov I, Bookout A, Wang Z, Staufenbiel M, Mangelsdorf D, Koldamova R
Molecular neurodegeneration 2007 Oct 22;2:20
Molecular neurodegeneration 2007 Oct 22;2:20
Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expression.
van der Hoogt CC, de Haan W, Westerterp M, Hoekstra M, Dallinga-Thie GM, Romijn JA, Princen HM, Jukema JW, Havekes LM, Rensen PC
Journal of lipid research 2007 Aug;48(8):1763-71
Journal of lipid research 2007 Aug;48(8):1763-71
High-fat/high-cholesterol diet promotes a S1P receptor-mediated antiapoptotic activity for VLDL.
Mihovilovic M, Robinette JB, DeKroon RM, Sullivan PM, Strittmatter WJ
Journal of lipid research 2007 Apr;48(4):806-15
Journal of lipid research 2007 Apr;48(4):806-15
Loss of polycystin-1 or polycystin-2 results in dysregulated apolipoprotein expression in murine tissues via alterations in nuclear hormone receptors.
Allen E, Piontek KB, Garrett-Mayer E, Garcia-Gonzalez M, Gorelick KL, Germino GG
Human molecular genetics 2006 Jan 1;15(1):11-21
Human molecular genetics 2006 Jan 1;15(1):11-21
No comments: Submit comment
No validations: Submit validation data